About Contact Us Careers
Sign In

Wilson Disease Drugs Market - Top Companies and Manufacturers

  • Report ID: 2863
  • Published Date: Jul 23, 2024
  • Report Format: PDF, PPT

Companies Dominating the Wilson Disease Drugs Landscape

    • Merck & Co., Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bausch Health Companies Inc.
    • Alexion Pharmaceuticals, Inc.
    • Nobelpharma Co., Ltd.
    • Kodmon Holdings, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Tsumura & Co.
    • VHB Medi Sciences Limited
    • Pfizer Inc.
    • Lupin Limited
    • Vivet Therapeutics
    • NAVINTA LLC
Browse Key Market Insights with Data Illustration:

In the News

  • Alexion Pharmaceuticals, Inc. made an announcement regarding the acquisition of LogicBio Therapeutic, Inc. The acquisition took place to accelerate the growth of Alexion Pharmaceuticals in developing genomic medicines using the unique technology of LogicBio.

  • Kadmon Holdings, Inc. announced that its generic Trientine Hydrochloride Capsules USP, 250 mg, which is a chelating agent used for the treatment of Wilson’s disease in patients who are intolerant of penicillamine, has been approved by the U.S. Food and Drug Administration (FDA).


Author Credits:  Radhika Pawar


  • Report ID: 2863
  • Published Date: Jul 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of wilson disease drugs is assessed at USD 648.83 Million.

The wilson disease drugs market size was over USD 625.2 Million in 2023 and is anticipated to reach USD 1.06 Billion by the end of 2036, witnessing around 4.2% CAGR during the forecast period i.e., between 2024-2036. Growing prevalence of Wilson’s disease in the young population and increasing health spending across the globe are the major factors driving the market growth.

North America is poised to dominate majority industry share by 2036, propelled by presence of leading market players in the region which manufacture and distribute Wilson disease drugs.

Merck & Co., Inc., Bausch Health Companies Inc., Alexion Pharmaceuticals, Inc., Nobelpharma Co., Ltd., Kodmon Holdings, Inc., Teva Pharmaceutical Industries Ltd., Tsumura & Co., VHB Medi Sciences Limited, Pfizer Inc., Lupin Limited, Vivet Therapeutics, NAVINTA LLC
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample